“Galectin-3 as a potential marker of myocardial hypertrophy in essential hypertension in individuals with polymorphic AT1R genotypes” (2018) Biomedical Research and Therapy, 5(8), pp. 2633–2644. doi:10.15419/bmrat.v5i8.471.